-
DE
Beta CrossLaps are breakdown products of bone collagen used as laboratory markers to assess bone resorption. They are measured in blood or urine.
Beta CrossLaps are breakdown products of bone collagen used as laboratory markers to assess bone resorption. They are measured in blood or urine.
Beta CrossLaps (also known as β-CrossLaps or Beta-CTX) are specific degradation products of type I collagen, the main structural protein of bone. They are released during the natural process of bone remodeling and enter the bloodstream, eventually appearing in urine. In clinical practice, Beta CrossLaps serve as bone resorption markers, providing insight into the rate at which bone tissue is being broken down.
Bone is continuously broken down and rebuilt in a process called bone remodeling. Specialized cells known as osteoclasts degrade old bone tissue by breaking down its collagen framework. This process generates small collagen fragments called C-terminal telopeptides of type I collagen (CTX-I). The beta form of these fragments – Beta CrossLaps – is particularly stable and easy to measure in the laboratory. They are detectable in blood serum and urine.
Measuring Beta CrossLaps in serum is primarily used for diagnosing and monitoring conditions associated with increased bone breakdown. Common clinical applications include:
Beta CrossLaps are typically measured from a blood sample (serum). Since values are strongly influenced by food intake, blood should be drawn in a fasting state, preferably early in the morning. Meals can significantly lower Beta CrossLaps concentrations and distort test results. Time of day and physical activity also affect measured values.
Reference ranges for serum Beta CrossLaps vary by laboratory, age, and sex. Typical guideline values are below 0.573 ng/ml for premenopausal women, below 1.008 ng/ml for postmenopausal women, and below 0.584 ng/ml for men under 50 years of age. Elevated values indicate increased bone resorption, while low values may suggest over-treatment or reduced bone turnover. Results must always be interpreted in the clinical context and alongside other parameters such as bone density measurement (DXA scan).
Beta CrossLaps are a valuable tool in modern osteoporosis diagnostics and therapy management. They allow early assessment of treatment response, often before changes in bone density become visible on imaging. This helps clinicians tailor therapy and monitor treatment success. However, Beta CrossLaps are not a standalone diagnostic criterion for osteoporosis; they complement other diagnostic methods and should be evaluated as part of a comprehensive assessment.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.